The role of short-chain fatty acid in metabolic syndrome and its complications: focusing on immunity and inflammation
Metabolic syndrome (Mets) is an important contributor to morbidity and mortality in cardiovascular, liver, neurological, and reproductive diseases. Short-chain fatty acid (SCFA), an organismal energy donor, has recently been demonstrated in an increasing number of studies to be an important molecule...
Saved in:
Main Authors: | Wenqian Yu, Siyuan Sun, Qiang Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1519925/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intestinal Short-Chain Fatty Acids in Patients with Bronchial Asthma
by: O. Yu. Zolnikova, et al.
Published: (2019-05-01) -
Metabolic Profiles of the Gut Microbiota in Patients with Different Stages of Metabolism Dysfunction-Associated Fatty Liver Disease
by: X. Cao, et al.
Published: (2024-10-01) -
Recovery of the Intestinal Microbiota Metabolic Activity in Patients with Bronchial Asthma
by: O. Yu. Zolnikova, et al.
Published: (2020-04-01) -
Metabolic and Genetic Determinants of Lipid Metabolism Disruption in Non-Alcoholic Fatty Liver Disease
by: O. Yu. Kytikova, et al.
Published: (2020-05-01) -
HIV and the gut microbiome: future research hotspots and trends
by: Zhen Wu, et al.
Published: (2025-02-01)